Manual of Blood Platelets: Morphology, Physiology and Pharmacology Gundu HR Rao
Page numbers followed by f refer to figure, t refer to table.
Abciximab 81, 82, 113, 142
Acetyl salicylic acid 106, 142
Acetylates COX enzymes 106
Adenosine 91, 126, 140, 184
diphosphate 15, 37, 40, 47, 102, 120, 149, 152f, 155f, 167, 183
receptor antagonists 88
triphosphate 42, 155f
Adenylyl cyclase, stimulators of 78, 88, 91
Adhesive molecule 121
Advance glycation end products 124
Alpha granules 3f
Amino acids 193
Angel-wing closure device 182f
Angina 143
unstable 91, 143
Angioplasty 143
Angiotensin-converting enzyme inhibitors 113
Annular perfusion
chamber 171f
devices 181
Anticancer molecules, targeted delivery of 196f
Antiplatelet drugs 79f, 91
clinical trials of 93
development of 90
pharmacology of 77, 91f
Antiplatelet therapies 88, 90
Aortic prostaglandins 32
Arachidonate 151, 154f
insensitive platelets 151
sensitive platelets 151
Arachidonic acid 20, 60, 91, 93, 102, 121, 150, 153, 167
metabolism 61f, 63f, 88, 102, 121, 122f
second messengers of 63f
response of 151
Arginine-glycine 169, 193
Arrhythmia, symptomatic cardiac 160
Arterial bypass surgery 143
Arterial disease, peripheral 91, 93, 106
Arterial thrombotic event, trigger of 123
Arterioles 166
Aspartic acid 169, 193
Aspirin 79, 88, 91, 94, 101, 106, 114, 142, 143, 190
clinical use of 103
mechanism of action of 106f
mediated inhibition of COX enzymes 64f
resistance 101, 106, 113
prevalence of 108
response units 111
Atherogenesis 121
Atherosclerosis 88, 101, 120
Atomic force microscopy 12, 13f
Average lumen diameter 167
Balloon catheter for blood compatibility, screening of 171f
Baumgartner perfusion chamber 170f
Benzoic acid 114
Benzydamine 91
Bernard-Soulier syndrome 29
Bileaflet heart valve 182f
Bleeding diathesis 41
Blood 14
biocompatibility studies 179
biomaterial interactions 194
validation of 185
cells 128
clot studies 180
components 128
role of 88
perfusion system 187
platelets 36, 70, 89, 120, 138
pressure 96
urea nitrogen 191
vessels, inflammatory disease of 88
Body mass index 89
Bovine platelet 31, 31f
Caffeine 79
antagonists 88, 91
chelators 91
in platelet activation, role of 55
ionophore 70
mobilization 72f
modulation 70
Capillaries, microembolization of 123
Carbenicillin 32
Carboxylate 80f
Cardiovascular disease 65, 77, 90
Cardiovascular drug delivery 195
Carotid endarterectomy 91
discoid 8
matrix components 174f
membranes 3f
Cell-cell interaction 22, 37f, 184
Cellular calcium homeostasis 89f
Ceramide-I-phosphate 49
artery disease 77
ischemia 106
Cerebrovascular disease 77, 91, 106
Chandler loop system 184f
Chediak-Higashi syndrome 24, 25, 27
Chlorpromazine 32
Chlortetracycline 56
Cholesterol 4, 137
Circulating blood cells and inflammation, activation of 139
Cirrhosis 22
Citrate, mixture of 184
Clopidogrel 79, 92, 94, 114
Coleonol 91
Collagen 39, 46
microfibrils 169f
Conventional electron microscopy 12
Coronary artery
graft 95
surgery 109
disease 77, 90, 91, 101, 120, 137, 158, 169
Coronary syndrome, acute 95, 101, 137, 160
Coumadin 190
C-reactive protein 88, 122, 138
Cross-eyed platelet 3f
Cyclic adenosine monophosphate 71, 114
Cyclic guanosine monophosphate 71, 149
Cyclic heptapeptide 82
Cyclic nucleotides 70
Cyclooxygenase 29, 71, 79, 101, 121, 138
deficiency 29, 154f
derived endothelium-dependent constriction factor 126, 168
inhibitors 78, 80f, 91
Cytosolic calcium 56
Dazoxiben 79
Dengue virus 22
Dense tubular system 2f, 3f, 5, 43, 55
Diabetes 88, 106, 120
mellitus 120, 124
pathogenesis of 128
Diabetic retinopathy 129
Diacylglycerol 58
Diamide 125
Didodecyldimethylammonium bromide 196
Dipyridamole 79, 184
Docosahexaenoic acid 65
Dog platelets 66f
nonresponsive 151
Drug-eluting stent 95
Dual antiplatelet therapy 94
Ectophosphatase 50
Eicosanoid 60, 64
metabolism 60
synthesis 60f
Electron microscopy 3f, 12
Elevated blood phosphorus 88, 138
Endoperoxides 30, 38, 102
Endoplasmic reticulum 5, 62
Endothelial cells 11, 65, 166f, 168f
monolayer of 11f, 166
vascular 126, 138
Endothelial dysfunction 88, 130
Endothelium 168f
dependent constriction factor, hypoxia-induced 140, 168
nonreactive 11f
vascular 11
Enzyme-linked immunosorbent assay 41, 185
Epinephrine 66f, 102, 151, 153, 154f, 167, 183
Eptifibatide 82
Estrogen 141
Ethylenediaminetetraacetic acid 19, 56, 80, 110
European Society of Cardiology 114
Extracellular matrix 7, 173
Fatty acid
polyunsaturated 61
synthetase 90
Fenoprofen 91
Ferrous iron
chelators 62
postulated model for interaction of 80f
Fibrinogen 4, 9, 39
internalization of 17f
Fibrinopeptide A 105
Fibronectin 4, 9, 39, 46
Fixed drug combinations 113
Flow cytometry 181
Fluorescence microscopy 14f
Flurbiprofen 91
Forskolin 91
Framingham study 141
Furosemide 32
Giant granule 27, 27f
Glanzmann thrombasthenia 22, 25
Glycogen 3f
Glycoprotein 40, 79, 88
domains 2f
Glycosaminoglycan 7
G-protein, agonist-mediated activation of 48f
Granule mobilization 15f, 18
Gray platelet syndrome 24, 25, 28, 28f, 56
Guanylyl cyclase 91
stimulators of 78, 88
Heart 141
disease 77, 88
coronary 106
failure, end-stage congestive 190f
valves 188
Heartmate pumps 190f
Hematological parameters, management of 129
Heme-indomethacin interaction, model for 81f
Hemolytic-uremic syndrome 22
Hemorrhagic disease 1
Heparin 22
Heptadecatrienoic acid 32
Hereditary intrinsic platelet disorders 22
Hermansky-Pudlak syndrome 24, 25, 26f, 56, 73
High-resolution atomic force microscopy 14f
Hormone 140
replacement therapy 137
Horse platelets 31
Hyperfunction 22
Hyperglobulinemia 32
Hyperglycemia 123, 130
mediated reactive oxygen 125
Hypertension 88, 120
pathogenesis of 120
Ibuprofen 79, 88, 91
Imidazole congeners 91
Immune thrombocytopenia 22
Incontinence, device for management of 182f
Indomethacin 79, 80f, 91
amide groups of 80f
phospholipid 56
trisphosphate 89
Ionized calcium, modulation of 55f
Ketanserin 79
Laminins 9, 39, 46
Left ventricular-assist devices 189
Leukotrienes 60
Lidocaine 32
Lipid phosphate phosphatases and platelet activation 49
high-density 88, 137
low-density 124, 138
Lipoxins 60
Low-molecular-weight heparin 83
Lysophosphatic acid 49
Macroglobulinemia 22
Megakaryocytes 1, 36
Membrane modulation, mechanism of 106, 149
Membrane system 5
Metabolic disorder, chronic 128
Microangiopathic hemolytic anemia 22
Mitochondria 2f
Monitoring antiplatelet therapies 143
Monitoring antithrombotic therapies 143
Multifactorial disease 138
Multiple myeloma 22, 32
Muscular arteries 167
Myocardial infarction 106, 137, 158
acute 91, 122
Myosin light chain 57, 127
phosphorylation of 152
Naproxen 91
Nephropathy 129
N-ethylmaleimide 125
Neuropathy 129
Nitric oxide 91, 126, 140
Nitroblue tetrazolium 80
Nitroglycerine 91
Nitroprusside 91
Noncommunicable disease 77
Noradrenaline 157
Nucleic acids 64
Obesity 130
Omega-3 fatty acids 114
Open canalicular system 2f, 5, 13, 43
Oxidative stress 124, 130
Parallel perfusion devices 181
Penicillin 32
Percutaneous coronary interventions 39, 92, 194
Peripheral venous disease 91
Phentolamine 32
Phenylbutazone 91
Phorbol myristate acetate 14, 46
Phosphatidic acid 49
Phosphatidyl inositol 4,5 bisphosphate, hydrolysis of 89
Phosphatidylcholine 4, 60
Phosphatidylethanolamine 4, 60
Phosphatidylinositol 4, 60, 61f, 89f
Phosphatidylserine 4
Phosphodiesterase 79
inhibitors 78
Phosphoinositide metabolism and platelet activation 49
Phospholipase 51, 156
C 39, 49f, 51f
activation of 71
D 49
Phospholipids 61
Phosphoprotein, vasodilator-stimulated 40, 73
Plasma membrane 55
Plasminogen activator inhibitor 123, 168f
Platelet 3f, 7, 36, 36f, 37f, 72f, 180
activating factor 15, 51, 79, 149, 168f
activation 37f, 39, 46, 50
and inactivation 58f
mechanisms 46
adhesion 79, 192
aggregation 50f, 72f, 181
and signaling pathways 79
studies 15
aggregometry studies 14
agonist-mediated stimulation of 138
biochemistry 18
circulate 7
cyclooxygenases 93
cytoskeleton 9f
dense tubular system 79
derived microparticles 123
disaggregation 50f, 72f
discoid 3f, 7f, 12f, 13f, 36f, 166f
disorders 25
acquired 32
common 24
dysfunction 120
in animal platelets 30
feeling surface 7f
fibrin filaments 17f
from giant microbes 3t
function 60, 183
analyzer 144
assay 109
miscellaneous dysfunction of 29
testing system 180
glycoprotein inhibitors 82
high-resolution scanning electron microscopy 13f
hyperfunction 88, 120, 121, 123, 124, 130, 137
risks of 137
hypersensitivity of 124
in blood, role of 183
in vascular pathology, role of 128
interaction 174f
on rabbit aorta 173f
with injured vessel wall 46f
with membrane filters 179
with subendothelium 172
associated integrin 2f
glycoprotein receptors 38
modulation 149
microparticles 88
microthrombi on collagen surface 169f
morphology and
dysfunction 22
function 7
of Glanzmann thrombasthenia 23f
on collagen fibrils 11f
physiology 36, 89, 102, 120, 138, 167, 183
poor plasma 170
production 22
reaction time 174
device, occluder for 182f
monitoring device 174f
testing 95f
reaggregation 50f, 72f
research laboratory 11
responses 8
rich plasma 30, 150, 170
spreading 37f, 173f
stimulates phospholipase C, agonist-mediated activation of 102
structure and activation mechanisms 47f
surface interactions 17f
fluorescent imaging of 169f
on subendothelium 169f
thrombus 10f
ultrastructure 2f
morphology 1
vessel wall interactions 166
with dense bodies 26f
Polylactic polyglycolic acid copolymer 196
Preexisting vascular lesions, local progression of 123
Progestin replacement therapy 141
Prostacyclin 62, 126, 140, 151, 152
Prostaglandin 38, 60, 64, 102
intermediates 40
thromboxanes and prostacyclin 123
metabolism 151
Prostate-specific membrane antigen 197
Protease-activated receptor 38
Protein 64
kinase C 14, 48, 61
phosphorylations 50
Proteoglycans 7, 9
Prothrombotic coagulation pathways 130
Pulmonary hemorrhage, exercise-induced 31
Pyrolytic carbon 187, 188
bileaflet heart valves 185
leaflets, mechanical 187
Red blood cell 36f, 138
Refractory platelets 152f
Retinopathy 129
Salicylic acid 81
Scanning electron microscopy 3f, 12, 12f
Scott syndrome 25
Screening valves, customized chamber for 187f
Serine protease inhibitors 78
Serotonin 79
Sheep vesicular glands 71
Signal transduction
mechanism 58f
pathways 61f
Signaling via phospholipase
C pathway 51f
D pathway 52f
Small vessel disease 91
Smooth muscle cell proliferation 195
Sphingosine 1-phosphate 49
Spread platelets, detergent-insoluble cytoskeleton of 42f
Storage pool
deficiency 24
disease 25
Streptozotocin 123
Stroke 41, 90, 101, 120, 140, 143
complete 91
pathogenesis of 124
research 180
statistics 77
Stromal interaction molecule 1 56
Surface-connected canalicular system 18
Synthetic polyelectrolytes 194
Systemic disorders 22
Temporary vascular-assist devices 190f
Testing heart valves, customized chamber for 182f
Theophylline 184
Thorium dioxide 18
Thrombin 40, 79, 102
Thrombocythemia 22
Thrombocytopenia 22
heparin-induced 32, 83
Thrombocytopenic purpura 22
Thrombosis 101, 120
pathogenesis of 124
Thrombotic disease 1
Thrombotic status analyzer 124
Thromboxane 38, 40, 60, 62, 71, 102
A2 78
A2 receptor blocker 79
antagonists 91
dysfunction 30, 48
synthase and receptor 79
synthetase inhibitors 78, 79, 91
Thrombus formation 88
Ticlopidine 79
Tissue plasminogen activator 124
Trans-Golgi vesicles in mega-karyocytes 24
Transient ischemic attack 91, 143
Trifluoromethyl 114
Tumor necrosis factor 122
Turkey platelets 32
Typical integrin dimer 39f
Unstable coronary syndromes 139
Uremia 22
Vascular disease, peripheral 93
Vascular dysfunction 120, 126, 139, 168
Vascular ischemic events, acute 88
Vascular tissues 104
Vasculopathy 129
Verapamil 67
Vessel wall
shear stress 167
thickness 167
Visceral adiposity 88
B12 88, 138
D 88
E 91, 125
Vitronectin 4, 39, 46
von Willebrand disease 28
von Willebrand factor 4, 16, 28, 38, 39, 47, 79, 90, 102, 121, 127, 139, 168, 168f, 174f
Vulnerable atherosclerotic plaque, rupture of 137
Watson-Marlow-Bredel pumps 187
Western blot 41
Wiskott-Aldrich syndrome 2426, 27f
Zn-pyrophosphate 197
Chapter Notes

Save Clear

fm1MANUAL OF BLOOD PLATELETS Morphology, Physiology and Pharmacology
Sponsored by
South Asian Society on Atherosclerosis and Thrombosis (SASAT)
Division of Clinical and Preventive Cardiology, Medanta Hospital
Gurugram, Haryana, India
fm3MANUAL OF BLOOD PLATELETS Morphology, Physiology and Pharmacology
Editor Gundu HR Rao PhD Emeritus Professor Laboratory Medicine and Pathology Director Thrombosis Research Lillehei Heart Institute Academic Health Center University of Minnesota Minneapolis, Minnesota, USA Foreword Jawed Fareed PhD DSc FAHA
Jaypee Brothers Medical Publishers (P) Ltd
Jaypee Brothers Medical Publishers (P) Ltd
4838/24, Ansari Road, Daryaganj
New Delhi 110 002, India
Phone: +91-11-43574357
Fax: +91-11-43574314
Overseas Offices
J P Medical Ltd
83 Victoria Street, London
Phone: +44 20 3170 8910
Fax: +44 (0)20 3008 6180
Jaypee Brothers Medical Publishers (P) Ltd
Bhotahity, Kathmandu, Nepal
Phone: +977-9741283608
Jaypee-Highlights Medical Publishers Inc
City of Knowledge, Bld. 235, 2nd Floor, Clayton
Panama City, Panama
Phone: +1 507-301-0496
Fax: +1 507-301-0499
© 2019, Jaypee Brothers Medical Publishers
The views and opinions expressed in this book are solely those of the original contributor(s)/author(s) and do not necessarily represent those of editor(s) of the book.
All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission in writing of the publishers.
All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book.
Medical knowledge and practice change constantly. This book is designed to provide accurate, authoritative information about the subject matter in question. However, readers are advised to check the most current information available on procedures included and check information from the manufacturer of each product to be administered, to verify the recommended dose, formula, method and duration of administration, adverse effects and contraindications. It is the responsibility of the practitioner to take all appropriate safety precautions. Neither the publisher nor the author(s)/editor(s) assume any liability for any injury and/or damage to persons or property arising from or related to use of material in this book.
This book is sold on the understanding that the publisher is not engaged in providing professional medical services. If such advice or services are required, the services of a competent medical professional should be sought.
Every effort has been made where necessary to contact holders of copyright to obtain permission to reproduce copyright material. If any have been inadvertently overlooked, the publisher will be pleased to make the necessary arrangements at the first opportunity. The CD/DVD-ROM (if any) provided in the sealed envelope with this book is complimentary and free of cost. Not meant for sale.
Inquiries for bulk sales may be solicited at :
Manual of Blood Platelets: Morphology, Physiology and Pharmacology
First Edition: 2019
Printed at
I dedicate this monograph to my mentor and associate
Regents Professor of Pediatrics and Pathology
(Late) James G White, MDfm6
This comprehensive book represents a detailed description of platelet biology highlighting the detailed structural and functional aspects of these anuclear cells. The illustrations and material included in this book represent a descriptive account of cutting edge work carried out during a 45-year period (1970–2015) and portray some of the lead discoveries on platelet structure and function. These discoveries have impacted the understanding of platelet-related diseases and the development of newer antiplatelet drugs, adding a new dimension to the treatment of cardiovascular diseases. Platelets were discovered accidentally by Professor Bizzozero in 1865 and since then have been a subject of focused basic and clinical research by experts from different disciplines. However, the work carried out at the University of Minnesota scientists led by Professor James White represents a major cornerstone in the overall development of platelet sciences. This book is a portrayal of the outstanding basic and clinical research on the structure and function of platelets and their interactions with the endothelium and other blood cells.
Of particular note, this book is a result of a very strong professional relationship between the author, Dr Rao and then lead hematologist at the University of Minnesota Professor James White, who was truly a pioneer in platelet related sciences. Dr Rao's recognition of the importance of compiling a complete account of the outstanding work carried out by Professor White is not only timely but is an inspirational tribute to a great mentor, Professor White. The compilation of this book and recognition of the pioneering work in nearly all aspects of platelet biology with a strong focus on the ultra-structure is the most appropriate way to acknowledge a mentor for which Dr Rao is to be commended. Professor White had dedicated most of his life to the study of platelets and related disorders. He himself was a 1955 graduate of the University of Minnesota Medical School, Minnesota, USA. After his initial training, he spent over 50 years at the same institution practicing hematology and overseeing a group of clinicians and scientists working on platelets. He is and will continue to be recognized as a lead investigator who applied great scientific vision and an integrated approach to identify the role of platelets in health and disease. His work on the fine structural details of platelets as they relate to the function of these anuclear cells revolutionized our understanding of the physiology and pharmacology of platelets. This book, illustrating the different aspects of platelet structure and function and a progressive evolution of innovative approaches resulting in various discoveries truly identifies him as a great mentor and leader. His interest in electron microscopy and its application to the study of platelets and blood cells encouraged the entire University of Minnesota team to advance this technique to its heights which resulted in the production of so many interesting images included some of which are included in the book. The photo micrographs and images generated at the University of Minnesota's hematology laboratories adorn the pages of the best hematology books all over the world and some of the lead publications carry these images and their references. Dr Rao has expertly summarized the complex fields of platelet morphology, physiology, pathology fm8and pharmacology in this monograph in a masterly fashion which is easy to read and will be of major value for the students and scholars working in the field of platelets.
This monograph is comprised of 16 chapters which are dexterously prepared with beautiful illustrations wherever applicable. The first chapter provides a very clear account of platelet morphology with specific reference to different structural components. The discussion on the structure is so well written that it can be understood by those with minimal background in hematology. The second chapter, dealing with platelet morphology and function, contains beautiful illustrations and a description of various techniques used to characterize functional morphology of platelets. Complimentary to this, the 3rd chapter interfaces platelet morphology with functional alterations in various diseases highlighting the structural components involved in some of these disorders. From an evolutionary stand point platelet dysfunction in animals is referenced to highlight some points. The 4th chapter deals with platelet physiology including the progressive changes in platelet regulatory actions. Once again the emphasis is on functional changes and the impact of structural alterations is highlighted. The 5th chapter deals with biochemical pathways involved in the platelet activation mechanism. For students working in signal transduction and other areas this will be important reading. Chapter 6 illustrates the role of calcium in platelet activation. Special emphasis is placed on modulation of ionized calcium by agonists and antagonists. The platelet activation and deactivation mechanisms are illustrated. Chapter 7 deals with the role of prostaglandins in platelet function whereas Chapter 8 discusses the calcium modulation by cyclic nucleotides.
The author has great expertise in the modulation of platelets by drugs and has masterfully described the pharmacology of antiplatelet drugs in Chapter 9. The mechanism of action of these drugs and their potential impact on treatment of diseases is also illustrated. Complimentary to this, Chapter 10 provides a comprehensive account of antiplatelet drugs in clinical trials. Of note, the work of the scientists at the University of Minnesota to develop point of care instrumentation to measure platelet response to antiplatelet drugs is highlighted. Once again stating the impact of physician/scientist collaboration at the University of Minnesota. Platelets have complex physiological processes and drug resistance is a major problem. Chapter 11 deals with aspirin resistance, a subject in which the author is an expert, and provides valuable guidelines to deal with this complication. Diabetes mellitus is associated with major platelet dysfunctions and this is beautifully illustrated in Chapter 12 in terms of the role of platelets in diabetes.
Professor Rao has a strong interest in acute coronary syndrome and is a great scholar of the pathophysiology and the pharmacologic management of this syndrome. In a very concise and masterful fashion, he has compiled Chapter 13 on platelet hyper-function as a risk factor for acute coronary events. In addition, the contribution of platelet activation of circulating blood cells and activation leading to vascular dysfunction is detailed. To address the monitoring of acute coronary events, the need for a point of care assay for monitoring antiplatelet and antithrombotic therapies is also discussed. Professor Rao rightly pointed to the fact that South Asians have a very high incidence of coronary artery disease suggesting the genetic components involved in this process. The membrane modulation concept was coined at the University of Minnesota where epinephrine mediated events were implicated. This led to the understanding of the initial mechanisms involved in the activation of platelets in health and disease. The role of alpha-adrenergic receptor antagonists and beta blockers in the modulation of this process was proposed. Chapter 15 discusses the platelet vessel fm9wall interaction which plays an important role in the progression of hemostatic plug and atherosclerotic plaque. The interplay between endothelial cells and platelets is illustrated. To investigate these interactions experimental approaches using the annular chamber profusion system are described. This chapter also contains some beautiful illustrations on the interactions of platelets and endothelial cells. Platelet reaction time (PRT) monitoring device to monitor sheer force mediated platelet activation and clot formation was also highlighted. The final chapter is dedicated to the discussion of blood biocompatibility studies with a focused reference to the contributions of the blood biocompatibility laboratory (BBL) at the medical school of the University of Minnesota. In this chapter, integrated approaches involving various groups including the faculty at the Lillehei Heart Institute are highlighted. This provided a strong academia-industry platform and the BBL offered the opportunity for medical device companies to work together to advance stroke research and other various scientific approaches to understand blood compatibility with surfaces, in particular the role of platelets in blood biomaterial interactions. Platelet physiology and function utilizing simple instruments as a Chandler loop coupled with electron-microscopic illustration of cellular activation validated blood biomaterial interactions. Other techniques dealing with blood cells under flow conditions, exposure of blood cells to fully assembled heart walls, and platelet adhesion to biomaterials were detailed. As the field of nano-microparticles emerged, this group also worked on cardiovascular drug delivery and targeting processes.
It can be easily seen that the evolution of platelet function with reference to morphometric alterations laid the foundation for a most comprehensive, multidisciplinary research approach including nearly all basic sciences. This would not have been possible without the intimate mentor trainee relationship which was initiated by Professor Jim White over 50 years ago. Dr Rao's recognition of Professor White's unparalleled drive and leadership resulted in a very productive group which continued to advance in the field of vascular medicine, the diagnosis of bleeding and thrombotic disorders related to platelets. Platelets are now considered to be an integral component of the vascular system. There is so much more to be learned. Advances in cellular and molecular biology have transformed platelet biology and have led us to recognize these cells in health and disease. This would not have been possible without the great vision of Professor White and his ability to recruit outstanding trainees, transforming them to lead physicians and scientists who will continue to impact this area for years to come. Professor Rao worked under Professor White and, like his mentor, has trained many younger scientists in the most integrated fashion bridging basic science and clinical medicine as portrayed in this book. While this book is a true tribute to Professor White at the Lillehei Heart Institute of the University of Minnesota which will remain a pioneering institution in cardiovascular research for years to come, its publication in India has a major significance including the outstanding talents in teaching and research and the pursuit for excellence. The information has direct relevance on the public health impact, in particular, the cardiovascular disease care in South Asian countries.
Jawed Fareed PhD DSc FAHA
Professor of Pharmacology and Pathology
Loyola University School of Medicine
Maywood, Illinois, USAfm10
Blood platelets play a very important role in the pathogenesis of atherosclerosis, thrombosis and stroke. In 1998, Kluwer Academic Publishers of Boston, USA contacted me and asked me to put together a Handbook on Platelet Physiology and Pharmacology. I recruited well-known national and international researchers, working in the area of atherosclerosis, thrombosis and stroke, to contribute articles for this book. I made a special request to all the contributors, to make an all-out effort to describe platelet morphology, biochemistry, physiology and pharmacology as it relates to function. When elite group of researchers develop a multidisciplinary project, by and large, they stick to their expertise and will not develop a cohesive, comprehensive story to summarize their collective experience. Our monograph was a collection of state-of-the-art topics, but failed to tell a story that summarizes what is known of platelets and how they work. Since then, I have discussed this issue many a times with my mentor, Prof James G White. We both were fascinated with the mechanisms involved in platelet activation and function. We discussed the topic, “How Platelet Works” many a times, in our long-working relationship. I wanted to put together a book on this subject with his help. However, I was not able to do it for various reasons, which are not worth discussing here. I came to know about his passing way, when I was vacationing in India this summer ( His obituary mentions, that he had over 700 articles to his credit. It made me feel bad, thinking about the missed opportunity for a collective description of our work, which lasted for forty years. Since the time, I received the news of his (Dr White's) deteriorating health from our close friend and associate Dr Gines Escolar from Barcelona, Spain (Currently resides in New Jersey, USA), I have been thinking nothing but to find a way to put together a monograph, that covers our four decades of work on Platelets. With these thoughts in mind, I approached our longtime friend (Mr Jitendar P Vij) at the Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India. They have published four of our books from 2001 to 2007, under the aegis of South Asian Society on Atherosclerosis and Thrombosis (SASAT). In spite of the fact that this is too specialized a subject and may attract only selected group of readers, they graciously accepted my request and agreed to publish this book. Electron photomicrographs that I have used in this book to illustrate platelet morphology and function, were gifted to me by late James G White. His long-term associate Ms Marlys Krumweide willingly prepared a set of slides for my use at various scientific conferences. I acknowledge my sincere thanks to them and dedicate this monograph to my mentor and associate, Regents Professor of Pediatrics and Pathology, James G White, MD. Many other illustrations were prepared for us for our presentations by the professional art and graphics department, at the University of Minnesota. Some of the illustrations, I have taken the liberty of borrowing from public domain (Internet). I also have taken liberty of using significant information from our previously published articles. The author assures the readers that the major part of the work presented in this book comes from the four decades of work done by Prof James G White, Prof Gundu HR Rao, and associates fm12at the Thrombosis Research Laboratory, Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota. In each chapter, author has provided references to published work of their own group as well as relevant references from other experts. At the end of the book, author has provided a complete bibliography of their work on platelets, for those who are interested in additional reference material to the source of information. We take this opportunity to sincerely thank all those who have contributed to our collective knowledge base.
One may wonder, why I am putting together a monograph on Blood Platelets? Recently I read a historical review on Platelets, which had over 400 references. I found only one reference to our work of 40 years and over 1000 articles collectively. This shows that either the reviewer has ignored completely our contribution to this collective knowledge or has no idea of their existence in the platelet literature. Either way, we feel that it is important to present our collective thoughts on this subject for the readers, who may be interested in looking at this topic from a different perspective. In addition to this reasoning, after reading several of these reviews, I found out, that they are like viewing a rain forest from sky. You see a canopy not individual tress. In this monograph, I will not try to catalogue all that is published on this subject. I will try to write more about how platelets work (read Platelet Story) rather than minute details, which may or may not make any sense to a beginner or for someone, who wants to get to know as to how platelet works. The monograph is compiled for the beginners, and for those who are new to this area and not for experts in this field of investigation.
Gundu HR Rao PhD
I would like to acknowledge significant contributions of Dr Jonathan Gerrard of Winnipeg, Canada, as well as Dr Gines Escolar of Barcelona, Spain, for our understanding of morphology, physiology and function of blood platelets. I have included references to the work of other researchers on this topic, so that those interested in learning more about specific pathways, mechanisms, will be able to access them. I express my sincere thanks to my father-in-law, Dr TN Ramachandra Rao, a pioneer scientist in our family, for his continued encouragement of my international activities. One of his wishes was, that I should put together a “single author” book on Platelets. I am glad that his wish is being fulfilled by the publication of this monograph. I express my sincere thanks to my wife, Dr Yashoda T Rao for her patience, cooperation and encouragement. I also would like to thank our grandson, Master Akshay R Tate, for his technical support in the preparation of this manuscript. I thank Mr Jitendar P Vij (Group Chairman), Mr Ankit Vij (Group President), Ms Chetna Malhotra Vohra (Associate Director—Content Strategy) and the team at Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, for taking the responsibility of publishing this book for our professional society, South Asian Society on Atherosclerosis and Thrombosis (SASAT), Division of Clinical and Preventive Cardiology, Medanta Hospital, Gurugram, Haryana, India.
In a book, that is dedicated to the memory of my mentor and associate, (Late) Prof James G White, I would be failing in my duty and responsibilities, if I do not mention the names of the other four mentors who shaped my professional career. First and the foremost, my PhD thesis adviser, (Late) Donald A Wilbur, Professor, Department of Entomology, Kansas State University, Manhattan, Kansas, Dr (Late) Neville Crawford, Professor and Head, Department of Biochemistry, Royal College of Surgeons, Lincoln Inn Fields, London, Dr (Late) Sir Vijay V Kakkar, Founder-Director, Thrombosis Research Institute, Emeritus Professor of Surgery, King's College, Denmark Hill Road, London and Dr (Late) MG Doni, Professor, Instituto di Fisiologia Umana (Institute of Human Physiology), University of Padova, Padova, Italy.fm14
fm19Four Decades of Global Collaborative Studies
Principal collaborator for these studies was Late James G White, mentor, and associate for over four decades. I will not be able to list all the collaborators by name. Hence, I humbly request all those who worked with us, if they do not see their names mentioned under this chapter, to excuse me. I do thank each and every one of them, for their valuable contributions. Dr Jonathan M Gerrard, a Canadian clinician joined us in the early 70s as a research fellow to do his PhD. He introduced us to eicosanoids. Prof John W Eaton, a molecular anthropologist in our department, introduced us to the free radical chemistry and their role in oxidation-reduction mechanisms. Dr Douglas Peterson, who was a freelance researcher worked with us for a short period and made significant contribution to our understanding of arachidonic acid-heme interactions as well as the role of epinephrine modulation of some of the steps in (Peterson DA, et al. Science. 1982;215:71-73) agonist-mediated signal transduction events. Dr Maurie J Stuart, a Professor from Children's Hospital, Thomas Jefferson University, Philadelphia, joined us a research fellow and worked with Dr Gerrard and our research group. For the first time, she demonstrated in a drug induced animal model, that the balance between prostaglandins from platelets and vessel wall is altered in hyperglycemic animals. Furthermore, she showed that islet cell transplantation in these animals restored the prostaglandin synthesis to normal levels. Chadwick A Cox, a Biochemist from Oklahoma University Health Center, Oklahoma, joined us as an honorary faculty and worked on topics related to platelet cytoskeletal rearrangements and phosphorylation of proteins associated with activation and inactivation processes (Cox AC, et al. J Cell Biol. 1984;98:8-15). Dr Douglas Weiss, a Professor in the Veterinary College, University of Minnesota, Minnesota and Gerhard J Johnson, an Adjunct faculty, Department of Medicine, University of Minnesota, Minnesota and a staff at the Veterans Administration Hospitals, collaborated with us on studies, which used various animal models.
In the areas of clinical studies, (Late) Prof Carl J Witkop, a pioneer and expert in studies on Albinism associated disorders, shared with us an National Institutes of Health (NIH) program project research grant on this topic and helped us work on patients with Albinism (Hermansky-Pudlak syndrome) from all over the world. We also shared an NIH program project with Prof Mark Nesbit, a pediatric oncologist, on bone marrow transplantation. In the cardiovascular research area, we shared an NIH program project with Prof Robert Vernier. In the basic sciences field, we shared an NIH program project grant with Prof Ellis Benson and Prof Andreas Rosenberg on Hemoglobinopathies. We collaborated extensively with Cardiology group (Prof Stanley Einzig, Prof Carl White, Prof Robert Wilson, Prof Gladwin Das). Professor James G White and I shared NIH research grants for well over three decades (36 years) including an NIH-Merritt Award for 10 years in the 80s.fm20
International Collaboration was a very important part of our activities. Dr Rao obtained a National Science Foundation (NSF) travel grant to visit India, in the 80s to establish bilateral research projects between the USA and India. Prof John W Eaton and Dr Rao visited India in the 80s. They visited major Medical Institutions from Kashmir in the North, to Thiruvananthapuram in the South. They gave lectures on various topics at each of this Medical Institution. Institutions visited included, Kashmir Medical College, Srinagar; Postgraduate Medical Institute, Chandigarh; All India Institute of Medical Sciences, New Delhi, National Malaria Institute, New Delhi; Postgraduate Medical Institute, Lucknow; Indian Institute of Science, Bengaluru; Postgraduate Medical Institute, Chennai; and Christian Medical College, Vellore. Dr Rao was a visiting Professor in the Department of Surgery (Prof Sir Vijay J Kakkar) and Pharmacology, King's College, Denmark Hills, London, in 1986 and in the Biochemistry Department (Prof Neville Crawford) in the Royal College of Surgeons, London, in the summer of 1987, and in the Thrombosis Research Institute (Prof VJ Kakkar), London in 1989. He taught one summer at the Institute of Human Physiology (Prof Maria Gabriella Doni), University of Padova, Padova, Italy. The Government of India, invited Dr Rao as a Senior Consultant in the year 1990, under a United Nations (UN) program called, TOKTEN (Transfer of Knowledge by Expatriate Nationals). Dr Khalilullah, Professor of Cardiology and Director of GB Pant Hospital, New Delhi, India, sponsored the application for this fellowship. Dr Rao spent 6 weeks in India visiting major Medical Institutions. Dr Rao visited India again in 1991 and 1992 under the same UN program.
With the seed money (USD 10,000) obtained from the International Society on Thrombosis and Hemostasis (ISTH), USA. Dr Rao started a professional society, South Asian Society on Atherosclerosis and Thrombosis (SASAT) in Minnesota in1993. Under the aegis of SASAT, he organized 15 international conferences on the topics of Atherosclerosis and Thrombosis in India. Dr. Rao served as senior adviser to the Presidents of North American Thrombosis Forum (Prof. Samuel Goldhaber, Harvard University:, International Union of Angiology (IUA), France.
fm21Platelet Story
I joined Late Professor James G White's group as an assistant scientist to establish an analytical laboratory, to conduct biochemical and functional studies, to follow his ultra-structural studies as well as to support his earlier findings with evidence-based biochemical investigations. Being new to this area, I was wondering as to how I can contribute anything more to his massive cumulative knowledge of the subject. I started off by setting up new analytical methods, to monitor various biochemical components of platelets (serotonin, adenine nucleotides, prostaglandins, cytosolic calcium), which were known to play a critical role in platelet physiology and function. Just at the beginning of my career in this department, Jonathan Gerrard a Canadian doctor joined our group to do his PhD (He is currently a Member of the Parliament in Manitoba). He spent over five years with us and was great moving force behind research into the emerging field of prostanoids.
Just at this time, we discovered that some specific fluorescent molecules (Quin-2 and Fura-2) could be used to monitor cytosolic free calcium. Using these techniques, we were for the first time, able to demonstrate the role of agonists in calcium mobilization from internal storage sites. We were able to demonstrate at the same time, that the antagonists were capable of lowering the elevated cytosolic calcium by activating adenylyl/guanylyl-cyclases and generating second messengers, cAMP and cGMP. These studies formed the basis for our simple platelet story. By this time, a young investigator from Barcelona, Spain, Dr Gines Escolar (Senior Consultant, Hemostasis Coagulation/Hemotherapy Hospital Clinic, Department of Hemotherapy and Hemostasis) joined us. He introduced us to, some newer techniques, to follow the platelet interactions with the vessel wall. Collective information that we gathered in these years formed the basis for the “Platelet Story”. During the four decades, that I spent at the University of Minnesota, we also were able to discover a unique phenomenon of “Membrane Modulation”, which is described in detail, in a later chapter in this book.
Investigations in our laboratory at the University of Minnesota established the existence of a novel mechanism capable of securing irreversible platelet aggregation independent of ADP secretion, prostaglandin synthesis or the generation of platelet activating factor (PAF). The new mechanism, termed membrane modulation, is associated with the platelet surface, mediated through alpha-adrenergic receptors and stimulated by exposure to epinephrine. Platelets rendered refractory to a variety of aggregating agents can be restored to a normal state of sensitivity through activation of the mechanism of membrane modulation. This included platelets treated with aspirin in vivo or in vitro. In view of the fact, that our studies demonstrated that the mechanism of platelet membrane modulation was dependent upon alpha-adrenergic receptor function, we explored the significance and nature of this dependency. Since these mechanisms seems to be critical for the restoration of the sensitivity of refractory platelets to the action of a variety of agonists, any impairment of alpha fm22adrenergic receptor function will therefore, interfere with the mechanism of membrane modulation.
Major contributions of the Platelet Research Laboratory, Laboratory Medicine and Pathology and the Thrombosis Research Laboratory, Lillehei Heart Institute, Academic Health Center, the University of Minnesota, include; superb Electron Microscopical Studies on Platelet Ultrastructure and function of normal human platelets, platelets of patients with various hematological disorders, and platelets of various animals. In view of the fact that these were not only state-of-the-art investigations at the cellular and subcellular level, but also one-of-a-kind studies, the National Institutes of Health, USA graciously funded these studies, for well over three decades. As a part of the original investigations at the Thrombosis Research Laboratory, we did a variety of biochemical studies to explore and complement the ultrastructural findings of Prof James G White.
Our association with Prof Gines Escolar and Dr Thomas Chandy introduced us to studies on blood-vessel interaction as well as blood-biomaterial interactions. Blood compatibility studies, were supported by the Departments of Chemical Engineering (Center for Interface Engineering), and the Biomedical Research Institute, Academic Health Center, the University of Minnesota. We were able to establish a state-of-the-art device/biomaterial testing facility and serve the Institute of Engineering Medicine, University of Minnesota as well as many device material manufacturing companies in the USA. One of my close associate (Dr Daniel Ericson), who joined us as an industrial fellow from 3M company, in the late 70s, established his own research laboratory (SUBc, Inc) at Rochester, Minnesota and developed two NIH (STTR) research grants for medical device development. IBM Rochester served as a contractor for the development of this device. I was the Principal Investigator for both of these device development research proposals. Multidisciplinary experience gained at the University of Minnesota, helped me initiate collaborative programs in India in several institutions. Since our research on platelets spanned over four decades, I have included a comprehensive bibliography of our collective work for readers who want to supplement their knowledge on this subject as a separate section at the end of this book.